| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |